Contrast-induced nephropathy (CIN) is a frequent complication of percutaneous coronary and peripheral artery interventions and is associated with significant in-hospital and long-term morbidity and mortality. We aim to compare the impact on major events of RenalGuard system(RG), continuous veno-venous Hemofiltration (CVVH) and hydration (Hy) with sodium bicarbonate plus N-acetylcysteine in patients with severe renal failure.
Renalguard, hemofiltration and hydration in prevention of contrast induced nephropathy in patients with severe chronic kidney disease undergoing percutaneous vascular interventions / Bertelli, L; Politi, L; Roversi, S; Bartolacelli, Y; Perrone, S; Becirovic, M; Zoccai, Gb; Bursi, F; Sangiorgi, Gm; Modena, Mg. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 33:(2012), pp. 1003-1004. (Intervento presentato al convegno CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY tenutosi a Munchen, GERMANY nel 25-29 AUGUST).
Renalguard, hemofiltration and hydration in prevention of contrast induced nephropathy in patients with severe chronic kidney disease undergoing percutaneous vascular interventions
Bertelli, L;Politi, L;Bartolacelli, Y;Becirovic, M;Modena, MG
2012
Abstract
Contrast-induced nephropathy (CIN) is a frequent complication of percutaneous coronary and peripheral artery interventions and is associated with significant in-hospital and long-term morbidity and mortality. We aim to compare the impact on major events of RenalGuard system(RG), continuous veno-venous Hemofiltration (CVVH) and hydration (Hy) with sodium bicarbonate plus N-acetylcysteine in patients with severe renal failure.File | Dimensione | Formato | |
---|---|---|---|
Abstract_.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
165.27 kB
Formato
Adobe PDF
|
165.27 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris